$ALAB

Mazzara Philip sold $2.3M of ALAB

Mazzara Philip (General Counsel and Secretary) sold 6,801 shares of Astera Labs, Inc. (ALAB) at an average of $340.50 ($333.64–$352.10, $2.32M total) across 18 trades on 2026-08-17.

Original reporting
SEC EDGAR · Mazzara Philip
Published Aug 19, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 10:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALAB
Bearish
medium confidence
Mentioned
$ALAB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALABBearishLow
01

Why it matters

The filing provides the first public disclosure of this insider sale, offering new data for traders.

02

Market read

Primary source filing introduces fresh insider sell data, modestly relevant for short-term traders.

03

What to watch

No disclosed 10b5-1 plan; the timing may be unrelated to company performance.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-19, reflects recent insider activity

Background

Astera Labs (ALAB) is a provider of data center connectivity solutions; insider transactions are monitored for potential signals.

Company-level read

Ticker impact

$ALABBearishMedium confidence
Context

General Counsel Philip Mazzara sold 6,801 shares for $2.3M, reducing his stake to 96,542 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

Officer-level insider selling $2.3M is material for a mid-cap, but no broader catalyst is present.

Market effects

Minimal impact on the broader semiconductor equipment sector.

Limited to U.S. markets where Astera Labs trades.

Low global relevance.

Counterpoint

The sale could be a routine diversification, not a negative signal.

Key entities

  • Astera Labs, Inc.

    Issuer of the Form 4 filing.

  • Philip Mazzara

    General Counsel and Secretary, insider seller.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALABMed

ALAB Stock Holds Support As High Valuation Tests Traders

Astera Labs Inc. (ALAB) stock rose 6.54% due to strong AI infrastructure demand. The company reported $392.4M in quarterly revenue, $153.1M in net income, and $67.2M in free cash flow. ALAB trades at 127x earnings and 37x sales, with a strong balance sheet but high valuation concerns. Traders are watching key price levels around $262–$265 and $272–$275.

$ALABMed

ALAB Broadens Leo Portfolio: Can It Stay Ahead of MRVL & CRDO?

Astera Labs (ALAB) reported record Q2 2026 revenue growth, driven by AI connectivity products. The company expanded its Leo CXL memory controller portfolio, gaining hyperscaler traction. Q3 2026 revenue is expected between $540M and $560M. Competitors Marvell (MRVL) and Credo (CRDO) are also advancing in AI connectivity. ALAB shares rose 51.8% YTD, with a forward P/S of 16.16X.

$ALABMed

Why Is Astera Labs Stock Down Today?

Astera Labs (NASDAQ: ALAB) shares dropped 10.1% on Sept. 14, 2026, after AI leaders called for slower AI development, threatening demand for its data-center networking products. The decline was steeper than the S&P 500's 0.3% and Nasdaq's 0.1% drops.

$ALABMed

Astera Labs’ Scorpio X Is Already in Volume Production. Citi Showed How Fast the Customer List Is Growing

Astera Labs (ALAB) announced its Scorpio X product line is in volume production and expects revenue growth, with customer engagements increasing. The company guided Q3 revenue to $540M-$560M. Shares dropped after missing S&P 500 inclusion. Analysts set a mid-target price of ~$715, citing potential total return of ~146%. Risks include customer concentration and valuation multiple compression.

$ALABMed

ALAB Gains From Aries and Taurus Strength: Can It Beat MRVL & CRDO?

Astera Labs (ALAB) reports strong Q2 2026 revenue growth driven by demand for Aries and Taurus connectivity solutions, with PCIe 6 products accounting for over 50% of total revenue. The company expects Q3 2026 revenues of $540M-$560M, up 40% sequentially. ALAB competes with Marvell (MRVL) and Credo (CRDO) in the AI connectivity market. ALAB's stock has surged 73.7% YTD, with a forward P/S of 18.64x.